DEPRESSIVE AND EXTRAPYRAMIDAL SYMPTOMS AND CLINICAL EFFECTS - TRIAL OF FLUPHENAZINE VERSUS FLUPENTHIXOL IN MAINTENANCE OF SCHIZOPHRENIC OUT-PATIENTS

被引：61

作者：

KNIGHTS, A ^{[1
]}

OKASHA, MS ^{[1
]}

ALISALIH, M ^{[1
]}

HIRSCH, SR ^{[1
]}

机构：

[1] YALE UNIV,SCH MED,NEW HAVEN,CT 06520

来源：

BRITISH JOURNAL OF PSYCHIATRY | 1979年 / 135卷 / DEC期

关键词：

D O I：

10.1192/bjp.135.6.515

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Fifty-seven patients with a diagnosis of schizophrenia were started on either fluphenazine decanoate or fluphenthixol decanoate injections in a double-blind trial just prior to discharge into the community. During the six month follow-up 30% dropped out of the treatment. Of those observed for 6 months, 7% relapsed, 54% experienced depressive symptoms and 88% extrapyramidal side-effects. Analysis of both clinical data and the ratings failed to discriminate between the two drugs.

引用

页码：515 / 523

页数：9

共 19 条

[1]

ALARCON RD, 1969, BRIT MED J, V3, P564

[2]

Carney M W, 1973, Curr Med Res Opin, V1, P423, DOI 10.1185/03007997309111704

[3] ANTIPARKINSONIAN AGENTS AND DEPOT PHENOTHIAZINE [J].